Interchangeable Biosimilars Market Share

APAC Market Statistics

The Asia Pacific interchangeable biosimilars market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036, on the back of advancement in the healthcare infrastructure, along with the growing number of researchers involved in R&D activities in the region. As per the data from the World Bank, there were 5331.15 researchers per million people in Japan, and 1307.121 per million people in China, as of 2018. Furthermore, the rising cases of chronic disorders and acute illnesses among the population are expected to increase the usage of advanced therapy medicinal products including interchangeable biosimilars are also estimated to drive the market in the Asia Pacific in the upcoming years.

North American Market Forecast

On the other hand, the market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing emergence of new pharmaceutical companies over the past decade, along with high investment in medical research activities. Further, the presence of a strong healthcare network in the region, with the addition of the availability of favorable policies by the regulatory bodies that promote the market players to opt for investing in more research works to bring up more feasible solutions so as to develop efficient interchangeable biosimilars options, are also anticipated to contribute to market growth in the region.